- Home
- ONCY vs GLV Comparison
ONCY vs GLV Comparison
Compare ONCY & GLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- GLV
- Stock Information
- Founded
- ONCY 1998
- GLV 2004
- Country
- ONCY Canada
- GLV United States
- Employees
- ONCY N/A
- GLV N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- GLV Finance/Investors Services
- Sector
- ONCY Health Care
- GLV Finance
- Exchange
- ONCY Nasdaq
- GLV Nasdaq
- Market Cap
- ONCY 56.2M
- GLV 72.1M
- IPO Year
- ONCY 1999
- GLV N/A
- Fundamental
- Price
- ONCY $0.70
- GLV $5.44
- Analyst Decision
- ONCY Strong Buy
- GLV
- Analyst Count
- ONCY 2
- GLV 0
- Target Price
- ONCY $4.00
- GLV N/A
- AVG Volume (30 Days)
- ONCY 2.6M
- GLV 54.2K
- Earning Date
- ONCY 03-06-2025
- GLV 01-01-0001
- Dividend Yield
- ONCY N/A
- GLV 12.44%
- EPS Growth
- ONCY N/A
- GLV N/A
- EPS
- ONCY N/A
- GLV N/A
- Revenue
- ONCY N/A
- GLV N/A
- Revenue This Year
- ONCY N/A
- GLV N/A
- Revenue Next Year
- ONCY N/A
- GLV N/A
- P/E Ratio
- ONCY N/A
- GLV N/A
- Revenue Growth
- ONCY N/A
- GLV N/A
- 52 Week Low
- ONCY $0.67
- GLV $4.70
- 52 Week High
- ONCY $1.53
- GLV $6.06
- Technical
- Relative Strength Index (RSI)
- ONCY 32.48
- GLV 41.73
- Support Level
- ONCY $0.67
- GLV $5.31
- Resistance Level
- ONCY $0.90
- GLV $5.56
- Average True Range (ATR)
- ONCY 0.05
- GLV 0.07
- MACD
- ONCY -0.01
- GLV -0.00
- Stochastic Oscillator
- ONCY 8.70
- GLV 44.83
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.
About GLV Clough Global Dividend and Income Fund of beneficial interest
Clough Global Dividend and Income Fund is a closed-ended investment management company. The fund's investment objective is to provide a high level of total return. It invests in equity and debt securities in both U.S. and non-U.S. markets of companies of any market capitalization.